Sulfonylurea-Induced Hypoglycemia in a Patient With Cirrhosis.

drug contraindications liver cirrhosis sulfonylurea compounds

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
08 Jun 2020
Historique:
entrez: 14 7 2020
pubmed: 14 7 2020
medline: 14 7 2020
Statut: epublish

Résumé

Type 2 diabetes mellitus is highly prevalent among patients with cirrhosis. The pharmacological management of this disease in patients with chronic liver disease remains controversial, however. Insulin secretagogues such as sulfonylureas are associated with a high risk of hypoglycemia among diabetics. In patients with cirrhosis, this risk is more pronounced due to decreased hepatic clearance, concurrent alcoholism, hypoalbuminemia, and acute liver decompensation. In this case report, we present a case of severe refractory hypoglycemia secondary to glipizide in a patient with alcoholic cirrhosis. We believe that the use of sulfonylureas in this patient population should be contraindicated to avoid debilitating neurologic damage and death following hypoglycemia.

Identifiants

pubmed: 32656029
doi: 10.7759/cureus.8513
pmc: PMC7346303
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e8513

Informations de copyright

Copyright © 2020, Braet et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Expert Opin Drug Metab Toxicol. 2014 Jun;10(6):839-57
pubmed: 24669954
Diabetes Care. 2018 Dec;41(12):2669-2701
pubmed: 30291106
Diabetes Care. 2007 Mar;30(3):734-43
pubmed: 17327353
Diabetes Metab Res Rev. 2019 Sep;35(6):e3157
pubmed: 30901133
Postgrad Med. 2012 Jul;124(4):130-7
pubmed: 22913901
Am J Med. 2007 Oct;120(10):829-34
pubmed: 17904449
Indian J Endocrinol Metab. 2015 Sep-Oct;19(5):577-96
pubmed: 26425465
Curr Pharm Des. 2005;11(21):2699-716
pubmed: 16101450
Indian J Endocrinol Metab. 2017 Mar-Apr;21(2):341-354
pubmed: 28459036
World J Gastroenterol. 2009 Jan 21;15(3):280-8
pubmed: 19140227
J Hepatol. 2000 Feb;32(2):209-17
pubmed: 10707860

Auteurs

Corey Braet (C)

Internal Medicine, University of Kansas School of Medicine-Wichita, Wichita, USA.

Yasmine Hussein Agha (Y)

Internal Medicine, University of Kansas School of Medicine-Wichita, Wichita, USA.

Ali Taleb (A)

Internal Medicine, University of Kansas School of Medicine-Wichita, Wichita, USA.

Charles Buess (C)

Internal Medicine, University of Kansas School of Medicine-Wichita, Wichita, USA.

John Millard (J)

Pharmacy, Robert J. Dole Veterans Affairs Medical Center, Wichita, USA.

Classifications MeSH